| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Stahlberg Jan is a 10% Owner at DiaMedica Therapeutics Inc.. Recent SEC Form 4 filings include 18 buys and 0 sells.
Estimated insider holdings value: $55.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | DMAC Diamedica Therapeutics Inc. | 10% Owner | Buy | 1,061,277 | $7.19 | $7,631,469.24 | +1.8% | -7.9% | - | |
| Aug 27, 2025 | DMAC Diamedica Therapeutics Inc. | 10% Owner | Buy | 1,000,000 | $5.96 | $5,958,106.80 | +1.5% | +51.0% | - | |
| Jul 23, 2025 | DMAC Diamedica Therapeutics Inc. | 10% Owner | Buy | 1,542,857 | $3.50 | $5,399,999.50 | +29.5% | +28.5% | - | |
| Jun 28, 2024 | DMAC Diamedica Therapeutics Inc. | 10% Owner | Buy | 1,200,000 | $2.50 | $3,000,000.00 | +29.8% | +45.8% | +30.2% |